Compelling Preclinical Kidney Cancer Results for Zantrene

Compelling Preclinical Breast Cancer Results
Race Oncology Limited (ASX: RAC) is pleased to share the final results of our collaborative…
Positive Early Preclinical Ovarian Cancer Results
Bisantrene found to be more effective compared to doxorubicin and epirubicin in ovarian cancer cell…
Race Initiates FTO-Directed Kidney Cancer Preclinical Study
Race enters a collaborative preclinical research program with The University of Newcastle to explore use…